173 related articles for article (PubMed ID: 12585658)
1. Contrast agents and temporal resolution in breast MR imaging.
Sardanelli F; Iozzelli A; Fausto A
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):69-75. PubMed ID: 12585658
[TBL] [Abstract][Full Text] [Related]
2. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced breast MR imaging.
Moon M; Cornfeld D; Weinreb J
Magn Reson Imaging Clin N Am; 2009 May; 17(2):351-62. PubMed ID: 19406363
[TBL] [Abstract][Full Text] [Related]
4. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
5. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging.
Hylton NM
Magn Reson Imaging Clin N Am; 2001 May; 9(2):321-32, vi. PubMed ID: 11493422
[TBL] [Abstract][Full Text] [Related]
6. [High-resolution T1-weighted MR-lymphography of inguinal lymph nodes after interstitial application of Gadomer-17 in animal experiments].
Staatz G; Spüntrup E; Klosterhalfen B; Misselwitz B; Pflüger D; Günther RW; Bücker A
Rofo; 2005 Jul; 177(7):968-74. PubMed ID: 15973599
[TBL] [Abstract][Full Text] [Related]
7. Update to pulse sequences for interventional MR imaging.
Derakhshan JJ; Duerk JL
Magn Reson Imaging Clin N Am; 2005 Aug; 13(3):415-29. PubMed ID: 16084410
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
[TBL] [Abstract][Full Text] [Related]
10. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in breast MRI and MRS.
Sinha S; Sinha U
NMR Biomed; 2009 Jan; 22(1):3-16. PubMed ID: 18654998
[TBL] [Abstract][Full Text] [Related]
12. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
[TBL] [Abstract][Full Text] [Related]
13. MR imaging of CNS tumors: are all contrast agents created the same?
Essig M
Neuroradiology; 2006 Apr; 48 Suppl 1():3-8. PubMed ID: 16699847
[TBL] [Abstract][Full Text] [Related]
14. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results.
Pinker K; Grabner G; Bogner W; Gruber S; Szomolanyi P; Trattnig S; Heinz-Peer G; Weber M; Fitzal F; Pluschnig U; Rudas M; Helbich T
Invest Radiol; 2009 Sep; 44(9):553-8. PubMed ID: 19652611
[TBL] [Abstract][Full Text] [Related]
15. Technical aspects of breast magnetic resonance imaging.
Hylton NM; Kinkel K
Top Magn Reson Imaging; 1998 Feb; 9(1):3-16. PubMed ID: 9617899
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced breast MRI at 7 Tesla utilizing a single-loop coil: a feasibility trial.
Umutlu L; Maderwald S; Kraff O; Theysohn JM; Kuemmel S; Hauth EA; Forsting M; Antoch G; Ladd ME; Quick HH; Lauenstein TC
Acad Radiol; 2010 Aug; 17(8):1050-6. PubMed ID: 20599158
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
Schnall MD; Blume J; Bluemke DA; DeAngelis GA; DeBruhl N; Harms S; Heywang-Köbrunner SH; Hylton N; Kuhl CK; Pisano ED; Causer P; Schnitt SJ; Thickman D; Stelling CB; Weatherall PT; Lehman C; Gatsonis CA
Radiology; 2006 Jan; 238(1):42-53. PubMed ID: 16373758
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging in suspected rectal cancer: determining tumor localization, stage, and sphincter-saving resectability at 3-Tesla-sustained high resolution.
Winter L; Bruhn H; Langrehr J; Neuhaus P; Felix R; Hänninen LE
Acta Radiol; 2007 May; 48(4):379-87. PubMed ID: 17453515
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features.
Goto M; Ito H; Akazawa K; Kubota T; Kizu O; Yamada K; Nishimura T
J Magn Reson Imaging; 2007 Jan; 25(1):104-12. PubMed ID: 17152054
[TBL] [Abstract][Full Text] [Related]
20. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
